 Aurelie Ledreux
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain-Derived Neurotrophic Factor | 5 | 2019 | 154 | 1.330 |
Why?
| | Down Syndrome | 8 | 2021 | 525 | 1.030 |
Why?
| | Alzheimer Disease | 7 | 2021 | 630 | 0.960 |
Why?
| | Hippocampus | 5 | 2020 | 971 | 0.950 |
Why?
| | Exosomes | 4 | 2019 | 104 | 0.900 |
Why?
| | Marine Toxins | 5 | 2012 | 12 | 0.870 |
Why?
| | Healthy Aging | 2 | 2019 | 44 | 0.670 |
Why?
| | Norepinephrine | 2 | 2017 | 201 | 0.610 |
Why?
| | Mindfulness | 2 | 2019 | 136 | 0.590 |
Why?
| | tau Proteins | 5 | 2020 | 105 | 0.570 |
Why?
| | Ciguatoxins | 2 | 2020 | 2 | 0.540 |
Why?
| | Memory, Short-Term | 2 | 2017 | 268 | 0.500 |
Why?
| | Spatial Memory | 1 | 2016 | 27 | 0.480 |
Why?
| | Aging | 2 | 2017 | 1969 | 0.470 |
Why?
| | Indans | 1 | 2015 | 13 | 0.460 |
Why?
| | Shellfish | 2 | 2012 | 6 | 0.460 |
Why?
| | Diet, High-Fat | 1 | 2016 | 266 | 0.430 |
Why?
| | Encephalitis | 1 | 2016 | 142 | 0.420 |
Why?
| | Learning | 1 | 2019 | 443 | 0.420 |
Why?
| | Cholesterol | 1 | 2016 | 408 | 0.410 |
Why?
| | Parkinson Disease | 2 | 2022 | 599 | 0.400 |
Why?
| | Neuroblastoma | 3 | 2013 | 174 | 0.400 |
Why?
| | Cognition | 3 | 2019 | 1266 | 0.390 |
Why?
| | Ciguatera Poisoning | 1 | 2013 | 2 | 0.390 |
Why?
| | Cooperative Behavior | 2 | 2012 | 462 | 0.360 |
Why?
| | Neurons | 2 | 2019 | 1649 | 0.360 |
Why?
| | Brain Concussion | 1 | 2019 | 644 | 0.320 |
Why?
| | Amyloid beta-Peptides | 4 | 2021 | 244 | 0.320 |
Why?
| | Exercise | 2 | 2019 | 2198 | 0.300 |
Why?
| | Memory Disorders | 2 | 2020 | 197 | 0.280 |
Why?
| | Acrylamides | 1 | 2008 | 74 | 0.280 |
Why?
| | Rats, Inbred F344 | 3 | 2017 | 268 | 0.270 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 848 | 0.250 |
Why?
| | Benzylamines | 2 | 2017 | 44 | 0.250 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.240 |
Why?
| | Biomarkers | 5 | 2023 | 4295 | 0.240 |
Why?
| | Locomotion | 2 | 2017 | 101 | 0.230 |
Why?
| | Brain | 4 | 2020 | 2947 | 0.230 |
Why?
| | Chromatography, Liquid | 2 | 2020 | 450 | 0.210 |
Why?
| | Cyanobacteria | 3 | 2014 | 51 | 0.210 |
Why?
| | Microglia | 2 | 2017 | 270 | 0.210 |
Why?
| | Tandem Mass Spectrometry | 3 | 2020 | 572 | 0.210 |
Why?
| | Rats | 4 | 2020 | 5584 | 0.200 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 28 | 0.190 |
Why?
| | Animals | 15 | 2020 | 38030 | 0.180 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2023 | 83 | 0.180 |
Why?
| | alpha-Synuclein | 1 | 2022 | 45 | 0.180 |
Why?
| | Amyloidogenic Proteins | 1 | 2020 | 16 | 0.160 |
Why?
| | Adrenergic Neurons | 1 | 2019 | 7 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 1 | 2020 | 37 | 0.150 |
Why?
| | Locus Coeruleus | 1 | 2019 | 25 | 0.150 |
Why?
| | Staining and Labeling | 1 | 2019 | 153 | 0.150 |
Why?
| | Male | 13 | 2020 | 72842 | 0.150 |
Why?
| | Protein Precursors | 1 | 2019 | 136 | 0.140 |
Why?
| | Healthy Lifestyle | 1 | 2019 | 37 | 0.140 |
Why?
| | Endocytosis | 1 | 2019 | 168 | 0.140 |
Why?
| | Analysis of Variance | 2 | 2017 | 1300 | 0.130 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 489 | 0.130 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2017 | 72 | 0.130 |
Why?
| | Nerve Degeneration | 1 | 2017 | 49 | 0.130 |
Why?
| | Cell Survival | 2 | 2013 | 1100 | 0.130 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 122 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 365 | 0.130 |
Why?
| | Microfilament Proteins | 1 | 2017 | 135 | 0.130 |
Why?
| | Chemokines | 1 | 2017 | 217 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 171 | 0.120 |
Why?
| | Calbindin 1 | 1 | 2016 | 1 | 0.120 |
Why?
| | Task Performance and Analysis | 1 | 2017 | 198 | 0.120 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 221 | 0.120 |
Why?
| | Bacterial Toxins | 2 | 2008 | 108 | 0.120 |
Why?
| | Microcystins | 2 | 2014 | 7 | 0.120 |
Why?
| | Chaperonin 60 | 1 | 2015 | 12 | 0.120 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 2015 | 20 | 0.120 |
Why?
| | Monoamine Oxidase | 1 | 2015 | 27 | 0.120 |
Why?
| | Phosphorylation | 2 | 2019 | 1707 | 0.120 |
Why?
| | Midazolam | 1 | 2016 | 73 | 0.120 |
Why?
| | Pyramidal Cells | 1 | 2016 | 80 | 0.110 |
Why?
| | Astrocytes | 1 | 2017 | 228 | 0.110 |
Why?
| | Interleukin-1beta | 1 | 2017 | 389 | 0.110 |
Why?
| | Diet, Western | 1 | 2016 | 88 | 0.110 |
Why?
| | Inhibitory Concentration 50 | 2 | 2012 | 90 | 0.110 |
Why?
| | Cell Line, Tumor | 4 | 2013 | 3542 | 0.110 |
Why?
| | Microtubule-Associated Proteins | 1 | 2016 | 194 | 0.110 |
Why?
| | Anesthetics | 1 | 2016 | 99 | 0.110 |
Why?
| | Neuroprotective Agents | 1 | 2015 | 147 | 0.100 |
Why?
| | Colorimetry | 1 | 2014 | 12 | 0.100 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 858 | 0.100 |
Why?
| | Single-Chain Antibodies | 1 | 2014 | 13 | 0.100 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1134 | 0.100 |
Why?
| | Memory | 1 | 2016 | 295 | 0.100 |
Why?
| | Water Microbiology | 1 | 2014 | 85 | 0.100 |
Why?
| | Alkaline Phosphatase | 1 | 2014 | 144 | 0.100 |
Why?
| | Neuroimaging | 1 | 2016 | 297 | 0.100 |
Why?
| | Dopamine | 1 | 2015 | 295 | 0.100 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 116 | 0.090 |
Why?
| | Half-Life | 1 | 2013 | 155 | 0.090 |
Why?
| | Sodium Channels | 1 | 2013 | 63 | 0.090 |
Why?
| | Injections, Intravenous | 1 | 2013 | 197 | 0.090 |
Why?
| | Chronic Disease | 1 | 2019 | 1808 | 0.090 |
Why?
| | Biological Availability | 1 | 2013 | 145 | 0.090 |
Why?
| | Humans | 15 | 2023 | 145474 | 0.090 |
Why?
| | Behavior, Animal | 1 | 2015 | 519 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 331 | 0.090 |
Why?
| | Escherichia coli Proteins | 1 | 2014 | 201 | 0.090 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4560 | 0.090 |
Why?
| | Cognition Disorders | 1 | 2016 | 541 | 0.090 |
Why?
| | Tropanes | 2 | 2008 | 5 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2014 | 1368 | 0.080 |
Why?
| | Administration, Oral | 1 | 2013 | 866 | 0.080 |
Why?
| | Cell Line | 2 | 2012 | 2823 | 0.080 |
Why?
| | Cnidarian Venoms | 1 | 2008 | 2 | 0.070 |
Why?
| | Bivalvia | 1 | 2008 | 6 | 0.070 |
Why?
| | Mice | 5 | 2019 | 18329 | 0.070 |
Why?
| | Torpedo | 1 | 2008 | 10 | 0.070 |
Why?
| | Biological Assay | 1 | 2008 | 130 | 0.070 |
Why?
| | Maze Learning | 2 | 2020 | 105 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2524 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5904 | 0.060 |
Why?
| | Aged | 4 | 2020 | 26153 | 0.060 |
Why?
| | Female | 6 | 2020 | 78844 | 0.060 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2008 | 280 | 0.060 |
Why?
| | Neurotoxins | 1 | 2005 | 28 | 0.060 |
Why?
| | Young Adult | 2 | 2019 | 14218 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2188 | 0.050 |
Why?
| | Poisoning | 1 | 2005 | 119 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3413 | 0.050 |
Why?
| | Amyloid | 1 | 2022 | 94 | 0.040 |
Why?
| | Autopsy | 1 | 2020 | 94 | 0.040 |
Why?
| | Seals, Earless | 1 | 2020 | 5 | 0.040 |
Why?
| | Acetonitriles | 1 | 2020 | 12 | 0.040 |
Why?
| | Designer Drugs | 1 | 2019 | 7 | 0.040 |
Why?
| | Limit of Detection | 1 | 2020 | 92 | 0.040 |
Why?
| | Solvents | 1 | 2020 | 112 | 0.040 |
Why?
| | Receptor, trkB | 1 | 2019 | 39 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 892 | 0.040 |
Why?
| | Adult | 2 | 2020 | 40777 | 0.040 |
Why?
| | Cell Communication | 1 | 2019 | 328 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 499 | 0.030 |
Why?
| | Voltage-Dependent Anion Channel 2 | 1 | 2016 | 1 | 0.030 |
Why?
| | Voltage-Dependent Anion Channel 1 | 1 | 2016 | 15 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2020 | 8333 | 0.030 |
Why?
| | Neuropathology | 1 | 2016 | 3 | 0.030 |
Why?
| | Intra-Abdominal Fat | 1 | 2016 | 101 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 461 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2016 | 155 | 0.030 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 467 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2017 | 608 | 0.030 |
Why?
| | Teaching | 1 | 2017 | 237 | 0.030 |
Why?
| | Coloring Agents | 1 | 2014 | 89 | 0.030 |
Why?
| | Liver | 2 | 2016 | 1896 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2016 | 693 | 0.020 |
Why?
| | Middle Aged | 3 | 2020 | 36215 | 0.020 |
Why?
| | Epitopes | 1 | 2014 | 473 | 0.020 |
Why?
| | Body Weight | 1 | 2016 | 971 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3342 | 0.020 |
Why?
| | Bungarotoxins | 1 | 2008 | 45 | 0.020 |
Why?
| | Color | 1 | 2008 | 81 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2008 | 75 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2028 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2440 | 0.020 |
Why?
| | Calibration | 1 | 2007 | 152 | 0.020 |
Why?
| | Reference Standards | 1 | 2007 | 177 | 0.020 |
Why?
| | Laboratories | 1 | 2007 | 110 | 0.020 |
Why?
| | Receptors, Nicotinic | 1 | 2008 | 327 | 0.010 |
Why?
| | Saxitoxin | 1 | 2005 | 2 | 0.010 |
Why?
| | Gastrointestinal Contents | 1 | 2005 | 8 | 0.010 |
Why?
| | France | 1 | 2005 | 40 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2007 | 592 | 0.010 |
Why?
| | Rivers | 1 | 2005 | 62 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2008 | 730 | 0.010 |
Why?
| | Dogs | 1 | 2005 | 458 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 2005 | 273 | 0.010 |
Why?
| | Environmental Monitoring | 1 | 2005 | 346 | 0.010 |
Why?
| | Intestines | 1 | 2005 | 354 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 22529 | 0.010 |
Why?
|
|
Ledreux's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|